Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Safety and efficacy of hepatitis B vaccination in cirrhosis of liver.

Roni DA, Pathapati RM, Kumar AS, Nihal L, Sridhar K, Tumkur Rajashekar S.

Adv Virol. 2013;2013:196704. doi: 10.1155/2013/196704. Epub 2013 Jun 6.

2.

[Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].

de Artaza Varasa T, Sánchez Ruano JJ, García Vela A, Gómez Rodríguez R, Romero Gutiérrez M, de la Cruz Pérez G, Gómez Moreno AZ, Carrobles Jiménez JM.

Gastroenterol Hepatol. 2009 Aug-Sep;32(7):483-8. doi: 10.1016/j.gastrohep.2009.03.009. Epub 2009 Jul 3. Spanish.

PMID:
19577338
3.

Screening for hepatitis A and B antibodies in patients with chronic liver disease.

Lau DT, Hewlett AT.

Am J Med. 2005 Oct;118 Suppl 10A:28S-33S. Review.

PMID:
16271538
4.

Anamnestic response to hepatitis B vaccine in nonalcoholic liver cirrhosis patients with and without HBV-DNA.

Baruch Y, Enat R, Gershoni-Baruch R, Rimon N, Ben-Porath E.

Am J Gastroenterol. 1992 May;87(5):613-6.

PMID:
1534439
5.

Need for immunization against hepatotropic viruses in children with chronic liver disease.

Srivastava A, Mathias A, Yachha SK, Agarwal J, Aggarwal R.

J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):393-7. doi: 10.1097/MPG.0000000000000437.

PMID:
24840513
6.

Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.

Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T.

Am J Gastroenterol. 2008 Jan;103(1):138-46. Epub 2007 Oct 26.

PMID:
17970833
7.
8.
9.

The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.

Zhang M, Wu R, Jiang J, Minuk GY, Niu J.

Alcohol. 2013 Nov;47(7):553-8. doi: 10.1016/j.alcohol.2013.07.003. Epub 2013 Sep 13.

PMID:
24041840
10.

Response to hepatitis B vaccine in Alaska natives with chronic alcoholism compared with non-alcoholic control subjects.

McMahon BJ, Wainwright K, Bulkow L, Parkinson AJ, Lindenbaum M, Wainwright R, Helminiak C.

Am J Med. 1990 May;88(5):460-4.

PMID:
2140010
11.

High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.

Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):203-8. doi: 10.1097/MPG.0b013e3181819ad4.

PMID:
19179883
12.

Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.

Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A.

Lancet. 1995 Apr 29;345(8957):1089-92.

PMID:
7715343
13.

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease.

Keeffe EB, Iwarson S, McMahon BJ, Lindsay KL, Koff RS, Manns M, Baumgarten R, Wiese M, Fourneau M, Safary A, Clemens R, Krause DS.

Hepatology. 1998 Mar;27(3):881-6.

PMID:
9500723
14.

[Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province: 24-month of follow-up from 2009].

Yan B, Lyu J, Liu J, Feng Y, Xu A, Chen S, Zhou L, Liang X, Cui F, Wang F, Zhang L.

Zhonghua Yu Fang Yi Xue Za Zhi. 2014 Dec;48(12):1043-7. Chinese.

PMID:
25619213
15.

Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.

Kallinowski B, Jilg W, Buchholz L, Stremmel W, Engler S.

Z Gastroenterol. 2003 Oct;41(10):983-90.

PMID:
14562195
16.

Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease.

Aziz A, Aziz S, Li DS, Murphy L, Leone N, Kennedy M, Dhillon S, Van Thiel DH.

J Viral Hepat. 2006 Apr;13(4):217-21.

PMID:
16611186
17.

Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.

Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ, Inskip HM, George MO, Whittle HC.

Lancet. 1993 May 1;341(8853):1129-31.

PMID:
8097813
18.

Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.

Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C.

J Infect Dis. 2005 May 1;191(9):1435-41. Epub 2005 Mar 28.

PMID:
15809901
19.

Hepatitis B virus vaccination for older adults.

Bennett RG, Powers DC, Remsburg RE, Scheve A, Clements ML.

J Am Geriatr Soc. 1996 Jun;44(6):699-703.

PMID:
8642163
20.

[Comparison of immunogenicity of vaccination and serovaccination against hepatitis B virus in patients with alcoholic cirrhosis].

Bronowicki JP, Weber-Larivaille F, Gut JP, Doffoël M, Vetter D.

Gastroenterol Clin Biol. 1997;21(11):848-53. French.

Supplemental Content

Support Center